Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Perrigo Company

Perrigo Company
1887 FOUNDED
PUBLIC STATUS
10K-15K EMPLOYEES
PRGO STOCK SYMBOL
37 INVESTMENTS
$48.82 SHARE PRICE (As of Thursday Closing)
Description

Perrigo is the largest store-brand over-the-counter pharmaceutical and infant formula manufacturer. The company operates three major segments: consumer healthcare, branded consumer healthcare, and prescription pharmaceuticals. As of mid-2018, Perrigo plans to divest the prescription segment. In the United States, Perrigo sells about 2,100 products with 9,000 stock-keeping units. Following the acquisition of Omega Pharma, approximately 30% of the company's revenue comes from outside the U.S.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
NYS
Primary Office
  • Treasury Building
  • Lower Grand Canal Street
  • Dublin 2
  • Ireland

+353 (01) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Perrigo Company’s full profile, request a free trial.

Perrigo Company Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$36.28 - $82.95 $6.63B $49.86 $0.95 1.26M 136M

Perrigo Company Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 8,085,641 7,927,041 17,450,177 13,193,327
Revenue 4,731,700 4,731,700 4,946,200 5,280,600
EBITDA 842,200 842,200 893,000 (4,174,700)
Net Income 131,000 131,000 119,600 (4,012,800)
Total Assets 10,983,400 10,983,400 11,628,800 13,870,100
Total Debt 3,242,400 3,242,400 3,341,200 5,797,300
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Perrigo Company Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.

Request full access to PitchBook

Perrigo Company Investments & Acquisitions (37)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 000000000000 27-Apr-2018 000000000 00000 00 Buildings and Property
00000, 000000 & 00 17-Aug-2016 000000000000000000 Personal Products 0000 00000000000
0000000 0000000000 25-Jan-2016 000000000000000000 00000 Pharmaceuticals 000000 0000
00000000 000000 (0 31-Dec-2015 000000000 00000 00 00000 Pharmaceuticals 000000 0000
Naturwohl Pharma 15-Sep-2015 Merger/Acquisition 00000 Distributors/Wholesale 000000 0000
To view this company’s complete investment and acquisition history, request access »

Perrigo Company Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 0000000000 01-Jan-2003 000000000000000000 Completed
  • 0000000 0000000
Vi-Jon 01-Dec-1994 Merger/Acquisition 0000 Completed
To view this company’s complete exits history, request access »

Perrigo Company Subsidiaries (6)

Company Name Industry Location Founded
Vedants Drugs and Fine Chemicals Pharmaceuticals Mumbai, India 2004
00000, 000000 & 00 Personal Products Peachtree City, GA 0000
00000 000000 Personal Products Nazareth, Belgium 0000
0000000 000000000 Pharmaceuticals Balcatta, Australia 0000
0000000 0000000000 Drug Delivery Ciudad Satélite, Mexico 0000
To view this company’s complete subsidiary history, request access »

Perrigo Company Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Perrigo Company‘s full profile, request access.

Request full access to PitchBook

Perrigo Company Executive Team (24)

Name Title Board
Seat
Contact
Info
Murray Kessler President, Chief Executive Officer & Board Member
Ron Winowiecki Chief Financial Officer
Sharon Kochan Executive Vice President and General Manager
James Michaud Executive Vice President and Chief Human Resources Officer
Thomas Farrington Chief Information Officer & Executive Vice President

12 Former Executives

You’re viewing 5 of 24 executives. Get the full list »